Quality-of-life issues and symptoms reported by patients living with haematological malignancy : a qualitative study
© The Author(s), 2020..
BACKGROUND: Our aim was to identify health-related quality-of-life (HRQoL) issues and symptoms in patients with haematological malignancies (HMs) and develop a conceptual framework to reflect the inter-relation between them.
METHODS: A total of 129 patients with HMs were interviewed in a UK multicentre qualitative study. All interviews were audio recorded, transcribed and analysed using NVivo-11.
RESULTS: Overall, 34 issues were reported by patients and were grouped into two parts: quality of life (QoL) and symptoms. The most prevalent HRQoL issues were: eating and drinking habits; social life; physical activity; sleep; and psychological well-being. Furthermore, most prevalent disease-related symptoms were: tiredness; feeling unwell; breathlessness; lack of energy; and back pain. The most prevalent treatment side effects were: tiredness; feeling sick; disturbance in sense of taste; and breathlessness.
CONCLUSIONS: Both HMs and their treatments have a significant impact on patients' HRQoL, in particular on issues such as job-role change, body image and impact on finances.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Therapeutic advances in hematology - 11(2020) vom: 01., Seite 2040620720955002 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Goswami, Pushpendra [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Clinical practice |
|---|
| Anmerkungen: |
Date Revised 17.04.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1177/2040620720955002 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM316704415 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM316704415 | ||
| 003 | DE-627 | ||
| 005 | 20231225161648.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/2040620720955002 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1055.xml |
| 035 | |a (DE-627)NLM316704415 | ||
| 035 | |a (NLM)33101618 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Goswami, Pushpendra |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Quality-of-life issues and symptoms reported by patients living with haematological malignancy |b a qualitative study |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 17.04.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © The Author(s), 2020. | ||
| 520 | |a BACKGROUND: Our aim was to identify health-related quality-of-life (HRQoL) issues and symptoms in patients with haematological malignancies (HMs) and develop a conceptual framework to reflect the inter-relation between them | ||
| 520 | |a METHODS: A total of 129 patients with HMs were interviewed in a UK multicentre qualitative study. All interviews were audio recorded, transcribed and analysed using NVivo-11 | ||
| 520 | |a RESULTS: Overall, 34 issues were reported by patients and were grouped into two parts: quality of life (QoL) and symptoms. The most prevalent HRQoL issues were: eating and drinking habits; social life; physical activity; sleep; and psychological well-being. Furthermore, most prevalent disease-related symptoms were: tiredness; feeling unwell; breathlessness; lack of energy; and back pain. The most prevalent treatment side effects were: tiredness; feeling sick; disturbance in sense of taste; and breathlessness | ||
| 520 | |a CONCLUSIONS: Both HMs and their treatments have a significant impact on patients' HRQoL, in particular on issues such as job-role change, body image and impact on finances | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a clinical practice | |
| 650 | 4 | |a clinical research | |
| 650 | 4 | |a haematological malignancy | |
| 650 | 4 | |a quality of life | |
| 650 | 4 | |a symptoms | |
| 700 | 1 | |a Oliva, Esther N |e verfasserin |4 aut | |
| 700 | 1 | |a Ionova, Tatyana |e verfasserin |4 aut | |
| 700 | 1 | |a Else, Roger |e verfasserin |4 aut | |
| 700 | 1 | |a Kell, Jonathan |e verfasserin |4 aut | |
| 700 | 1 | |a Fielding, Adele K |e verfasserin |4 aut | |
| 700 | 1 | |a Jennings, Daniel M |e verfasserin |4 aut | |
| 700 | 1 | |a Karakantza, Marina |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Ismail, Saad |e verfasserin |4 aut | |
| 700 | 1 | |a Collins, Graham P |e verfasserin |4 aut | |
| 700 | 1 | |a McConnell, Stewart |e verfasserin |4 aut | |
| 700 | 1 | |a Langton, Catherine |e verfasserin |4 aut | |
| 700 | 1 | |a Salek, Sam |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Therapeutic advances in hematology |d 2010 |g 11(2020) vom: 01., Seite 2040620720955002 |w (DE-627)NLM224608940 |x 2040-6207 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2020 |g day:01 |g pages:2040620720955002 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/2040620720955002 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2020 |b 01 |h 2040620720955002 | ||